PRQR logo

ProQR Therapeutics NV (PRQR) Shareholders Equity

Annual Shareholders Equity

$45.75 M
-$26.17 M-36.38%

December 31, 2023


Summary


Performance

PRQR Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Quarterly Shareholders Equity

$27.90 M
-$7.31 M-20.77%

September 1, 2024


Summary


Performance

PRQR Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

PRQR Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-36.4%-43.1%
3 y3 years-34.8%-56.3%
5 y5 years-57.0%-56.3%

PRQR Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-64.5%at low-78.3%at low
5 y5-year-64.5%at low-81.3%at low
alltimeall time-65.6%>+9999.0%-81.3%>+9999.0%

ProQR Therapeutics NV Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$27.90 M(-20.8%)
Jun 2024
-
$35.22 M(-6.3%)
Mar 2024
-
$37.60 M(-17.8%)
Dec 2023
$45.75 M(-36.4%)
$45.75 M(-6.7%)
Sep 2023
-
$49.05 M(-12.8%)
Jun 2023
-
$56.28 M(-12.5%)
Mar 2023
-
$64.34 M(-10.5%)
Dec 2022
$71.92 M(-44.2%)
$71.92 M(+12.7%)
Sep 2022
-
$63.81 M(-30.1%)
Jun 2022
-
$91.26 M(-18.9%)
Mar 2022
-
$112.54 M(-12.7%)
Dec 2021
$128.88 M(+83.5%)
$128.88 M(-13.6%)
Sep 2021
-
$149.17 M(+6.1%)
Jun 2021
-
$140.55 M(+141.1%)
Mar 2021
-
$58.30 M(-17.0%)
Dec 2020
$70.22 M(-33.5%)
$70.22 M(-12.8%)
Sep 2020
-
$80.57 M(-10.6%)
Jun 2020
-
$90.08 M(-0.2%)
Mar 2020
-
$90.30 M(-14.5%)
Dec 2019
$105.66 M
$105.66 M(+61.3%)
Sep 2019
-
$65.50 M(-18.4%)
Jun 2019
-
$80.31 M(-11.9%)
DateAnnualQuarterly
Mar 2019
-
$91.11 M(-14.3%)
Dec 2018
$106.29 M(+125.1%)
$106.29 M(-10.8%)
Sep 2018
-
$119.19 M(+350.7%)
Jun 2018
-
$26.44 M(-27.4%)
Mar 2018
-
$36.43 M(-22.9%)
Dec 2017
$47.22 M(-15.9%)
$47.22 M(+22.4%)
Sep 2017
-
$38.58 M(-8.3%)
Jun 2017
-
$42.08 M(-13.9%)
Mar 2017
-
$48.88 M(-13.0%)
Dec 2016
$56.17 M(-42.8%)
$56.17 M(-18.5%)
Sep 2016
-
$68.92 M(-12.6%)
Jun 2016
-
$78.90 M(-13.2%)
Mar 2016
-
$90.89 M(-7.4%)
Dec 2015
$98.18 M(-26.2%)
$98.18 M(-8.8%)
Sep 2015
-
$107.60 M(-5.6%)
Jun 2015
-
$114.00 M(-4.2%)
Mar 2015
-
$119.05 M(-10.5%)
Dec 2014
$133.04 M(<-9900.0%)
$133.04 M(-5.7%)
Sep 2014
-
$141.10 M(+204.0%)
Jun 2014
-
$46.42 M(<-9900.0%)
Dec 2013
-$122.90 K(-193.9%)
-$122.90 K
Dec 2012
$130.90 K
-

FAQ

  • What is ProQR Therapeutics NV annual stockholders equity?
  • What is the all time high annual shareholders equity for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual shareholders equity year-on-year change?
  • What is ProQR Therapeutics NV quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly shareholders equity year-on-year change?

What is ProQR Therapeutics NV annual stockholders equity?

The current annual shareholders equity of PRQR is $45.75 M

What is the all time high annual shareholders equity for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual stockholders equity is $133.04 M

What is ProQR Therapeutics NV annual shareholders equity year-on-year change?

Over the past year, PRQR annual stockholders equity has changed by -$26.17 M (-36.38%)

What is ProQR Therapeutics NV quarterly stockholders equity?

The current quarterly shareholders equity of PRQR is $27.90 M

What is the all time high quarterly shareholders equity for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly stockholders equity is $149.17 M

What is ProQR Therapeutics NV quarterly shareholders equity year-on-year change?

Over the past year, PRQR quarterly stockholders equity has changed by -$21.15 M (-43.12%)